Skip to main content

Table 1 Baseline patient characteristics

From: Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy

Characteristica N (%) [Mean, SD]
Years of age [48.7, 15.3]
Male sex 148 (64.9)
Race
 African American 182 (79.8)
 Caucasian 34 (14.9)
 Hispanic 6 (2.6)
 Native Hawaiian 1 (0.4)
 Asian 2 (0.9)
 Native American 2 (0.9)
 Other 1 (0.4)
CrCl (ml/min) (n = 187) [74.3, 32.8]
BMI (n = 187) [26.8, 9.2]
Nephrotoxic agents
 IV contrast 50 (21.9)
 Aminoglycoside 8 (3.5)
 NSAID 31 (13.7)
 Tenofovir 13 (5.7)
 2 or more agents 17 (7.5)
Comorbidities
 Diabetes 49 (21.5)
 Hypertension 91 (39.9)
 Malignancy 16 (7.0)
 CKD 12 (5.3)
 HIV 50 (21.9)
 2 or more of the above comorbidities 65 (28.5)
Indication for antibiotics
 Sepsis unknown etiology 26 (11.8)
 Pneumonia 44 (19.3)
 Bacteremia 7 (3.1)
 Skin/soft tissue infection 76 (33.3)
 Intra-abdominal 20 (8.8)
 Central nervous system 2 (0.9)
 Urinary tract 9 (4.0)
 Bone/joint 41 (18.0)
  1. SD standard deviation
  2. an = 228 unless otherwise stated